M

sudden death, 16-17 Magnesium metabolism, 425 torsades de pointes, 388 VT, 340 Mahaim fiber tachycardia children, 462 Mapping entrainment scar-related tachycardias, 368-379 MAT, 32, 42

Maternal-fetal circulatory system, 491-492 Maze III operation, 133-134, 155-156 complications, 134 results, 134 Methylamphetamine syncope, 186 Methyldopa orthostatic hypotension, 199 Methylphenidate syncope, 202 Metoprolol AF, 102-103

postoperative, 112 pregnancy, 498 Mexiletine pregnancy, 496 VT, 235

Microvolt T-wave alternans (TWA), 20-21 Micturition syncope pacemakers, 220 Minimal structural heart disease disopyramide, 108-109 flecainide, 108-109 procainamide, 108-109 propafenone, 108-109 quinidine, 108-109 Mini-Maze, 134 Mirowski, Michel, 5 Mitral regurgitation

AF, 81 Mitral stenosis

AF, 81 Mobitz I block, 443 Mobitz II block, 444-446 Molecular genetics congenital LQTS, 380-381 Monomorphic ventricular tachycardia, 238-255 ACE inhibitors, 240-241 amiodarone, 241-244

nonischemic dilated cardiomyopathy, 244, 246 associated diseases, 252-253 beta blockers, 240 catheter ablation, 249 ecainide, 241 enalapril, 240-241 flecainide, 241

hemodynamically intolerable, 248-250 antiarrhythmic drug therapy, 248-249 sotalol, 249 hemodynamically tolerable, 250-252 hydralazine, 241 ICD, 242-243, 249-251 isosorbide, 241 moricizine, 241

nonischemic dilated cardiomyopathy antiarrhythmic drug therapy, 244 ICD, 244-245 nonsustained primary prevention nonischemic dilated cardiomyopathy,

244-245 prior MI, 240-244 prior MI, 342 propranolol, 240 reversible triggers, 247-248 risk-stratifying variables, 238-240 secondary prevention, 247-252 structurally normal heart, 255 type 3 antiarrhythmic agents, 241-242 type I antiarrhythmic agents, 241 Moricizine adverse effects, 336 CAST, 241, 279, 450 monomorphic VT, 241 pregnancy, 496 M-PATHY, 224, 407 MRI

Brugada syndrome, 394 MSA, 196

Multicenter Automatic Defibrillator Implantation Trial (MADIT), 6, 16-17, 242, 280-283, 305-307 sudden death, 16-17 Multicenter Study of Pacing Therapy for Hypertrophic Cardiomyopathy (M-PATHY), 224, 407 Multicenter Unsustained Tachycardia Trial (MUSTT), 6, 17, 243, 252, 277-278, 280-283, 307-310 Multifocal atrial tachycardia (MAT)

pathophysiology, 32, 42 Multiple System Atrophy (MSA), 196 MUSTT. See Multicenter Unsustained

Tachycardia Trial Myocardial bridges

VT, 348-349 Myocarditis acute with NSVT, 290 AF, 81 VT, 350-351

How To Reduce Acne Scarring

How To Reduce Acne Scarring

Acne is a name that is famous in its own right, but for all of the wrong reasons. Most teenagers know, and dread, the very word, as it so prevalently wrecks havoc on their faces throughout their adolescent years.

Get My Free Ebook


Post a comment